Görgişen, G. Et Al. 2012. In vitro phosphorylation levels of insulin receptor substrate 1 (IRS1) from mononuclear cells of type 2 diabetes patients can be used as diagnostic marker for insulin responsiveness. EMBO Diabetes and Obesity Symposium , (Heidelberg, Germany), 1.

Görgişen, G., CELIK, F., GOKKAYA, M., BALCI, M., OZDEM, S., & OZES, O. N., (2012). In vitro phosphorylation levels of insulin receptor substrate 1 (IRS1) from mononuclear cells of type 2 diabetes patients can be used as diagnostic marker for insulin responsiveness . EMBO Diabetes and Obesity Symposium (pp.1). Heidelberg, Germany

Görgişen, Gökhan Et Al. "In vitro phosphorylation levels of insulin receptor substrate 1 (IRS1) from mononuclear cells of type 2 diabetes patients can be used as diagnostic marker for insulin responsiveness," EMBO Diabetes and Obesity Symposium, Heidelberg, Germany, 2012

Görgişen, Gökhan Et Al. "In vitro phosphorylation levels of insulin receptor substrate 1 (IRS1) from mononuclear cells of type 2 diabetes patients can be used as diagnostic marker for insulin responsiveness." EMBO Diabetes and Obesity Symposium , Heidelberg, Germany, pp.1, 2012

Görgişen, G. Et Al. (2012) . "In vitro phosphorylation levels of insulin receptor substrate 1 (IRS1) from mononuclear cells of type 2 diabetes patients can be used as diagnostic marker for insulin responsiveness." EMBO Diabetes and Obesity Symposium , Heidelberg, Germany, p.1.

@conferencepaper{conferencepaper, author={Gökhan Görgişen Et Al. }, title={In vitro phosphorylation levels of insulin receptor substrate 1 (IRS1) from mononuclear cells of type 2 diabetes patients can be used as diagnostic marker for insulin responsiveness}, congress name={EMBO Diabetes and Obesity Symposium}, city={Heidelberg}, country={Germany}, year={2012}, pages={1} }